That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address.

Joseph Shulman Biography and Net Worth

Insider of Rhythm Pharmaceuticals

Joe Shulman was promoted to Chief Technical Officer in 2022. He had joined Rhythm as our Senior Vice President, Technical Operations in July 2020. Joe brings more than 20 years of industry experience and is responsible for chemistry, manufacturing, and controls (CMC), clinical and commercial supply chains, and cGMP quality assurance and quality control. Prior to joining Rhythm, Joe served as Senior Vice President of Technical Operations at Ra Pharmaceuticals, acquired by UCB in 2020, where he oversaw all aspects of CMC development, pre-commercialization supply chain planning and strategy as a member of the executive leadership team. Before that, he was senior vice president of global technical operations at Novelion Therapeutics, where he had responsibility for CMC, quality assurance, program management, patient/hub services, and global patient supply of Juxtapid® and Myalept®, two globally marketed products for rare metabolic diseases. Earlier in his career, Joe held roles of increasing responsibility at biotechnology companies in the areas of CMC, technical operations, and program and alliance management. He holds an M.B.A. from Boston University and earned a B.S. in chemical engineering from Miami University.

What is Joseph Shulman's net worth?: The estimated net worth of Joseph Shulman is at least $1,800.60 as of July 16th, 2024. Mr. Shulman owns 30 shares of Rhythm Pharmaceuticals stock worth more than $1,801 as of November 21st. This net worth approximation does not reflect any other investments that Mr. Shulman may own. Additionally, Mr. Shulman receives a salary of $677,270.00 as Insider at Rhythm Pharmaceuticals. Learn More about Joseph Shulman's net worth.
How old is Joseph Shulman?: Mr. Shulman is currently 48 years old. There are 5 older executives and no younger executives at Rhythm Pharmaceuticals. The oldest executive at Rhythm Pharmaceuticals is Dr. David P. Meeker M.D., Chairman, President & CEO, who is 70 years old. Learn More on Joseph Shulman's age.
What is Joseph Shulman's salary?: As the Insider of Rhythm Pharmaceuticals, Inc., Mr. Shulman earns $677,270.00 per year. There are 4 executives that earn more than Mr. Shulman. The highest earning executive at Rhythm Pharmaceuticals is Dr. David P. Meeker M.D., Chairman, President & CEO, who commands a salary of $1,350,000.00 per year. Learn More on Joseph Shulman's salary.
How do I contact Joseph Shulman?: The corporate mailing address for Mr. Shulman and other Rhythm Pharmaceuticals executives is 222 BERKELEY STREET 12TH FLOOR, BOSTON MA, 02116. Rhythm Pharmaceuticals can also be reached via phone at (857) 264-4280 and via email at [email protected]. Learn More on Joseph Shulman's contact information.
Has Joseph Shulman been buying or selling shares of Rhythm Pharmaceuticals?: Over the course of the past ninety days, Joseph Shulman has sold $882,389.64 of Rhythm Pharmaceuticals stock. Most recently, Joseph Shulman sold 13,281 shares of the business's stock in a transaction on Monday, November 11th. The shares were sold at an average price of $66.44, for a transaction totalling $882,389.64. Learn More on Joseph Shulman's trading history.
Who are Rhythm Pharmaceuticals' active insiders?: Rhythm Pharmaceuticals' insider roster includes Pamela Cramer (Insider), Jennifer Good (Director), Jennifer Lee (EVP), Yann Mazabraud (EVP), David Meeker (CEO), Joseph Shulman (Insider), Hunter Smith (CFO), and Lynn Tetrault (Director). Learn More on Rhythm Pharmaceuticals' active insiders.
Are insiders buying or selling shares of Rhythm Pharmaceuticals?: In the last twelve months, insiders at the sold shares 26 times. They sold a total of 410,931 shares worth more than $20,497,452.48. The most recent insider tranaction occured on November, 11th when EVP Jennifer Kayden Lee sold 66,861 shares worth more than $4,434,890.13. Insiders at Rhythm Pharmaceuticals own 5.6% of the company. Learn More about insider trades at Rhythm Pharmaceuticals.
Information on this page was last updated on 11/11/2024.

Joseph Shulman Insider Trading History at Rhythm Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/11/2024	Sell	13,281	$66.44	$882,389.64
7/16/2024	Sell	10,468	$53.00	$554,804.00	30
7/12/2024	Sell	5,313	$50.01	$265,703.13	30
5/9/2024	Sell	3,984	$38.47	$153,264.48	30
3/21/2024	Sell	18,235	$40.34	$735,599.90	30
2/14/2024	Sell	1,089	$50.01	$54,460.89	30
2/12/2024	Sell	791	$51.38	$40,641.58	3,457
2/9/2024	Sell	71,774	$50.38	$3,615,974.12	2,686
12/27/2023	Sell	5,015	$50.01	$250,800.15	1,126
2/14/2023	Sell	554	$26.87	$14,885.98	3,741
2/15/2022	Sell	557	$6.10	$3,397.70

Joseph Shulman Buying and Selling Activity at Rhythm Pharmaceuticals

Rhythm Pharmaceuticals Company Overview

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $60.02

$58.02

$60.09

50 Day Range

MA: $52.94

$47.20

$67.33

2 Week Range

Now: $60.02

$31.52

$68.58

Volume

65,792 shs

Average Volume

546,862 shs

Market Capitalization

$3.69 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.09

[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

From Crypto Swap Profits | Ad

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Joseph Shulman Biography and Net Worth

What is Joseph Shulman's net worth?

How old is Joseph Shulman?

What is Joseph Shulman's salary?

How do I contact Joseph Shulman?

Has Joseph Shulman been buying or selling shares of Rhythm Pharmaceuticals?

Who are Rhythm Pharmaceuticals' active insiders?

Are insiders buying or selling shares of Rhythm Pharmaceuticals?